FDA.reportPublic FDA data

Xerava 100 MG Injection

RxCUI
2374558
RxNorm name
Xerava 100 MG Injection
Display name
Xerava 100 MG Injection
Full name
Xerava 100 MG Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XeravaERAVACYCLINETetraphase Pharmaceuticals, Inc.a4b188d4-f467-470c-ad7b-25ffbdd8862a2025-03-31Warnings, Adverse reactionsExact identifier
rxcui: 2374558

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a4b188d4-f467-470c-ad7b-25ffbdd8862aXERAVA 100 MG Injection [PSN] · eravacycline 100 MG Injection [Xerava] [SBD] · Xerava 100 MG Injection [SY]311These highlights do not include all the information needed to use XERAVA safely and effectively. See full prescribing information for XERAVA. XERAVA ® (eravacycline) for injection, for intravenous use Initial U.S. Approval: 201820250922